Literature DB >> 23730220

History and pathogenesis of lynch syndrome.

Brian J Bansidhar1, Jennifer Silinsky.   

Abstract

Lynch syndrome is the familial clustering of colorectal and endometrial cancers. This syndrome is passed in an autosomal dominant fashion within families with defective mismatch repair as the genetic basis for cancer development in these patients. There remains a group of patients who fit clinical diagnostic criteria for an autosomal dominant familial cancer syndrome, which is phenotypically similar to Lynch syndrome, but for which no mismatch repair mutation is identified. Identification of alternate genetic mutations such as EPCAM and CHEK2 may explain the cancer risk in a small subset of these patients, but continuing work into the genetic basis of colorectal familial cancer syndromes is needed.

Entities:  

Keywords:  CHEK2; EPCAM; Lynch syndrome; hereditary nonpolyposis colorectal cancer; microsatellite instability; mismatch repair

Year:  2012        PMID: 23730220      PMCID: PMC3423881          DOI: 10.1055/s-0032-1313776

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  18 in total

1.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

2.  EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients.

Authors:  Carla Guarinos; Adela Castillejo; Víctor-Manuel Barberá; Lucía Pérez-Carbonell; Ana-Beatriz Sánchez-Heras; Angel Segura; Carmen Guillén-Ponce; Ana Martínez-Cantó; María-Isabel Castillejo; Cecilia-Magdalena Egoavil; Rodrigo Jover; Artemio Payá; Cristina Alenda; José-Luís Soto
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

Review 3.  DNA mismatch repair defects: role in colorectal carcinogenesis.

Authors:  Sandrine Jacob; Françoise Praz
Journal:  Biochimie       Date:  2002-01       Impact factor: 4.079

4.  Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age.

Authors:  Sanjay Kakar; Lawrence J Burgart; Stephen N Thibodeau; Kari G Rabe; Gloria M Petersen; Richard M Goldberg; Noralane M Lindor
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

5.  The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.

Authors:  J M Cunningham; C Y Kim; E R Christensen; D J Tester; Y Parc; L J Burgart; K C Halling; S K McDonnell; D J Schaid; C Walsh Vockley; V Kubly; H Nelson; V V Michels; S N Thibodeau
Journal:  Am J Hum Genet       Date:  2001-08-24       Impact factor: 11.025

6.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

7.  Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.

Authors:  Masakazu Yashiro; Kosei Hirakawa; C Richard Boland
Journal:  BMC Cancer       Date:  2010-06-18       Impact factor: 4.430

8.  Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.

Authors:  Renée C Niessen; Robert M W Hofstra; Helga Westers; Marjolijn J L Ligtenberg; Krista Kooi; Paul O J Jager; Marloes L de Groote; Trijnie Dijkhuizen; Maran J W Olderode-Berends; Harry Hollema; Jan H Kleibeuker; Rolf H Sijmons
Journal:  Genes Chromosomes Cancer       Date:  2009-08       Impact factor: 5.006

9.  The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.

Authors:  Hanne Meijers-Heijboer; Juul Wijnen; Hans Vasen; Marijke Wasielewski; Anja Wagner; Antoinette Hollestelle; Fons Elstrodt; Renate van den Bos; Anja de Snoo; Grace Tjon A Fat; Cecile Brekelmans; Shantie Jagmohan; Patrick Franken; Paul Verkuijlen; Ans van den Ouweland; Pamela Chapman; Carli Tops; Gabriela Möslein; John Burn; Henry Lynch; Jan Klijn; Riccardo Fodde; Mieke Schutte
Journal:  Am J Hum Genet       Date:  2003-04-10       Impact factor: 11.025

10.  Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.

Authors:  R E Johnson; G K Kovvali; L Prakash; S Prakash
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

View more
  4 in total

1.  Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.

Authors:  Guo-Li Gu; Xiao-Quan Zhu; Xue-Ming Wei; Li Ren; De-Chang Li; Shi-Lin Wang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

2.  Rectal Cancer Diagnosed after Cesarean Section in Which High Microsatellite Instability Indicated the Presence of Lynch Syndrome.

Authors:  Tomohiro Okuda; Hiroshi Ishii; Sadao Yamashita; Sakura Ijichi; Seiki Matsuo; Hiroyuki Okimura; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2015-05-07

Review 3.  Upper Gastrointestinal Cancer Surveillance in Lynch Syndrome.

Authors:  Shria Kumar; Natalie Farha; Carol A Burke; Bryson W Katona
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

4.  Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study.

Authors:  Kathleen F Mittendorf; Jessica Ezzell Hunter; Jennifer L Schneider; Elizabeth Shuster; Alan F Rope; Jamilyn Zepp; Marian J Gilmore; Kristin R Muessig; James V Davis; Tia L Kauffman; Kellene M Bergen; Georgia L Wiesner; Louise S Acheson; Susan K Peterson; Sapna Syngal; Jacob A Reiss; Katrina A B Goddard
Journal:  Hered Cancer Clin Pract       Date:  2019-12-16       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.